the analysis of the course and issues of the disease in 1424 patients with operable cancer of the mammary gland indicated that using of the postoperative chemotherapy increases a 5-year survival without recurrences and metastases , on an average , by 10 % , while in early tumors ( without regional metastases ) -- by 15-20 % .
C0012634
disease
C0027651
tumors